Type II diabetes mellitus
Clinical trials for Type II diabetes mellitus explained in plain language.
Never miss a new study
Get alerted when new Type II diabetes mellitus trials appear
Sign up with your email to follow new studies for Type II diabetes mellitus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New diabetes drug CX11 shows promise in major trial
Disease control Recruiting nowThis study tests a new medication, CX11, for people with type 2 diabetes who need better blood sugar control despite taking metformin. About 240 adults will receive different doses of CX11 or a placebo for 24 weeks to see if it safely lowers blood sugar. The goal is to find the b…
Matched conditions: TYPE II DIABETES MELLITUS
Phase 2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Online shopping tricks aim to boost whole grain intake in diabetes patients
Disease control Recruiting nowThis study tests whether personalized marketing messages and discounts can encourage people with prediabetes or type 2 diabetes to switch from refined grains to whole grains when shopping for groceries online. About 216 adults aged 45-70 from the Philadelphia area who already sho…
Matched conditions: TYPE II DIABETES MELLITUS
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New weekly shot shows promise for diabetes and weight loss
Disease control Recruiting nowThis study tests a new weekly injection called GL0034 in 285 adults with type 2 diabetes who are overweight or obese. Participants will receive either the study drug or a placebo for about 36 weeks. The main goal is to see if GL0034 helps lower blood sugar levels more than a plac…
Matched conditions: TYPE II DIABETES MELLITUS
Phase 2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New diabetes drug safety check underway in pakistan
Disease control Recruiting nowThis study is checking how safe and well-tolerated the diabetes drug empagliflozin (taken with or without metformin) is in Pakistani adults with type 2 diabetes. About 2000 people aged 18-65 with poorly controlled blood sugar will be followed for 6 months. The study will track si…
Matched conditions: TYPE II DIABETES MELLITUS
Phase 4 • Sponsor: Getz Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could community groups curb diabetes? massive trial launches in pakistan
Disease control Recruiting nowThis trial tests whether a community-based learning program can help prevent and control type 2 diabetes in rural Pakistan. Over 12,000 adults aged 20 and older will participate in group sessions focused on healthy behaviors. The study will measure changes in blood sugar levels a…
Matched conditions: TYPE II DIABETES MELLITUS
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Jun 26, 2026 13:20 UTC
-
Village meetings aim to curb diabetes in rural afghanistan
Prevention Recruiting nowThis study tests a community-based program in rural Kabul, Afghanistan, to help prevent and control type 2 diabetes. About 250 adults aged 20 and older will take part in group learning and action meetings. The goal is to see if this approach is practical and well-liked by the com…
Matched conditions: TYPE II DIABETES MELLITUS
Sponsor: HealthNet Transcultural Psychosocial Organization • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Simple exercises may ease nerve pain in menopause
Symptom relief Recruiting nowThis study tests whether a combination of sensory-motor exercises (like pelvic rocking and strength training) can reduce pain and improve balance in postmenopausal women with polyneuropathy. One hundred women with type 2 diabetes and numbness in their arms and legs will be random…
Matched conditions: TYPE II DIABETES MELLITUS
Sponsor: New Ismailia National University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New diabetes drug studied in kidney patients
Knowledge-focused Recruiting nowThis early-stage study tests how a single dose of the diabetes drug GL0034 behaves in people with different levels of kidney function. About 40 adults with type 2 diabetes will be grouped by kidney health, from normal to severe impairment. Researchers will measure drug levels in …
Matched conditions: TYPE II DIABETES MELLITUS
Phase 1 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC